World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance

Alkomiet Hasan; Peter Falkai; Thomas Wobrock; Birte Glenthoj; Wagner F Gattaz; Florence Thibaut; A Carlo Altamura; Nancy Andreasen; Thomas R E Barnes; M Emin Ceylan; Jorge Ciprian Ollivier; Timothy Crow; Aysen Esen Danaci; Anthony David; Michael Davidson; Bill Deakin; Helio Elkis; Lars Farde; Wolfgang Gaebel; Bernd Gallhofer; Jes Gerlach; Steven Richard Hirsch; Carlos Roberto Hojaij; Michael Hwang; Hai Gwo Hwo; Assen Verniaminov Jablensky; Marek Jarema; John Kane; Takuja Kojima; Veronica Larach; Jeffrey Lieberman; Patrick McGorry; Herbert Meltzer; Hans-Jürgen Möller; S Mosolov; Driss Moussaoui; Jean-Pierre Olié; Antonio Pacheco Palha; Asli Sarandöl; Mitsumoto Sato; Heinrich Sauer; Nina Schooler; Bilgen Taneli; Lars von Knorring; Daniel Weinberger; Shigeto Yamawaki

doi:10.3109/15622975.2012.696143

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance

Alkomiet Hasan, Peter Falkai, Thomas Wobrock, Birte Glenthoj, Wagner F Gattaz, Florence Thibaut, A Carlo Altamura (Collaborator), Nancy Andreasen (Collaborator), Thomas R E Barnes (Collaborator), M Emin Ceylan (Collaborator), Jorge Ciprian Ollivier (Collaborator), Timothy Crow (Collaborator), Aysen Esen Danaci (Collaborator), Anthony David (Collaborator), Michael Davidson (Collaborator), Bill Deakin (Collaborator), Helio Elkis (Collaborator), Lars Farde (Collaborator), Wolfgang Gaebel (Collaborator), Bernd Gallhofer (Collaborator)Jes Gerlach (Collaborator), Steven Richard Hirsch (Collaborator), Carlos Roberto Hojaij (Collaborator), Michael Hwang (Collaborator), Hai Gwo Hwo (Collaborator), Assen Verniaminov Jablensky (Collaborator), Marek Jarema (Collaborator), John Kane (Collaborator), Takuja Kojima (Collaborator), Veronica Larach (Collaborator), Jeffrey Lieberman (Collaborator), Patrick McGorry (Collaborator), Herbert Meltzer (Collaborator), Hans-Jürgen Möller (Collaborator), S Mosolov (Collaborator), Driss Moussaoui (Collaborator), Jean-Pierre Olié (Collaborator), Antonio Pacheco Palha (Collaborator), Asli Sarandöl (Collaborator), Mitsumoto Sato (Collaborator), Heinrich Sauer (Collaborator), Nina Schooler (Collaborator), Bilgen Taneli (Collaborator), Lars von Knorring (Collaborator), Daniel Weinberger (Collaborator), Shigeto Yamawaki (Collaborator)

Research output: Contribution to journal › Article › peer-review

Abstract

These updated guidelines are based on a first edition of the World Federation of Societies of Biological Psychiatry Guidelines for Biological Treatment of Schizophrenia published in 2005. For this 2012 revision, all available publications pertaining to the biological treatment of schizophrenia were reviewed systematically to allow for an evidence-based update. These guidelines provide evidence-based practice recommendations that are clinically and scientifically meaningful and these guidelines are intended to be used by all physicians diagnosing and treating people suffering from schizophrenia. Based on the first version of these guidelines, a systematic review of the MEDLINE/PUBMED database and the Cochrane Library, in addition to data extraction from national treatment guidelines, has been performed for this update. The identified literature was evaluated with respect to the strength of evidence for its efficacy and then categorised into six levels of evidence (A-F; Bandelow et al. 2008b, World J Biol Psychiatry 9:242). This first part of the updated guidelines covers the general descriptions of antipsychotics and their side effects, the biological treatment of acute schizophrenia and the management of treatment-resistant schizophrenia.

Original language	English
Journal	The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry
Volume	13
Issue number	5
DOIs	https://doi.org/10.3109/15622975.2012.696143
Publication status	Published - Jul 2012

Access to Document

10.3109/15622975.2012.696143

Fingerprint

Dive into the research topics of 'World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance'. Together they form a unique fingerprint.

Cite this

Hasan, A., Falkai, P., Wobrock, T., Glenthoj, B., Gattaz, W. F., Thibaut, F., Altamura, A. C., Andreasen, N., Barnes, T. R. E., Ceylan, M. E., Ciprian Ollivier, J., Crow, T., Danaci, A. E., David, A., Davidson, M., Deakin, B., Elkis, H., Farde, L., Gaebel, W., ... Yamawaki, S. (2012). World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 13(5). https://doi.org/10.3109/15622975.2012.696143

Hasan, Alkomiet ; Falkai, Peter ; Wobrock, Thomas et al. / World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1 : update 2012 on the acute treatment of schizophrenia and the management of treatment resistance. In: The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry. 2012 ; Vol. 13, No. 5.

@article{29e8be318d28465e83c6b20206f1cef7,

title = "World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance",

abstract = "These updated guidelines are based on a first edition of the World Federation of Societies of Biological Psychiatry Guidelines for Biological Treatment of Schizophrenia published in 2005. For this 2012 revision, all available publications pertaining to the biological treatment of schizophrenia were reviewed systematically to allow for an evidence-based update. These guidelines provide evidence-based practice recommendations that are clinically and scientifically meaningful and these guidelines are intended to be used by all physicians diagnosing and treating people suffering from schizophrenia. Based on the first version of these guidelines, a systematic review of the MEDLINE/PUBMED database and the Cochrane Library, in addition to data extraction from national treatment guidelines, has been performed for this update. The identified literature was evaluated with respect to the strength of evidence for its efficacy and then categorised into six levels of evidence (A-F; Bandelow et al. 2008b, World J Biol Psychiatry 9:242). This first part of the updated guidelines covers the general descriptions of antipsychotics and their side effects, the biological treatment of acute schizophrenia and the management of treatment-resistant schizophrenia.",

author = "Alkomiet Hasan and Peter Falkai and Thomas Wobrock and Birte Glenthoj and Gattaz, {Wagner F} and Florence Thibaut and Altamura, {A Carlo} and Nancy Andreasen and Barnes, {Thomas R E} and Ceylan, {M Emin} and {Ciprian Ollivier}, Jorge and Timothy Crow and Danaci, {Aysen Esen} and Anthony David and Michael Davidson and Bill Deakin and Helio Elkis and Lars Farde and Wolfgang Gaebel and Bernd Gallhofer and Jes Gerlach and Hirsch, {Steven Richard} and Hojaij, {Carlos Roberto} and Michael Hwang and Hwo, {Hai Gwo} and Jablensky, {Assen Verniaminov} and Marek Jarema and John Kane and Takuja Kojima and Veronica Larach and Jeffrey Lieberman and Patrick McGorry and Herbert Meltzer and Hans-J{\"u}rgen M{\"o}ller and S Mosolov and Driss Moussaoui and Jean-Pierre Oli{\'e} and Palha, {Antonio Pacheco} and Asli Sarand{\"o}l and Mitsumoto Sato and Heinrich Sauer and Nina Schooler and Bilgen Taneli and {von Knorring}, Lars and Daniel Weinberger and Shigeto Yamawaki",

year = "2012",

month = jul,

doi = "10.3109/15622975.2012.696143",

language = "English",

volume = "13",

journal = "The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry",

issn = "1814-1412",

publisher = "Taylor & Francis",

number = "5",

}

Hasan, A, Falkai, P, Wobrock, T, Glenthoj, B, Gattaz, WF, Thibaut, F, Altamura, AC, Andreasen, N, Barnes, TRE, Ceylan, ME, Ciprian Ollivier, J, Crow, T, Danaci, AE, David, A, Davidson, M, Deakin, B, Elkis, H, Farde, L, Gaebel, W, Gallhofer, B, Gerlach, J, Hirsch, SR, Hojaij, CR, Hwang, M, Hwo, HG, Jablensky, AV, Jarema, M, Kane, J, Kojima, T, Larach, V, Lieberman, J, McGorry, P, Meltzer, H, Möller, H-J, Mosolov, S, Moussaoui, D, Olié, J-P, Palha, AP, Sarandöl, A, Sato, M, Sauer, H, Schooler, N, Taneli, B, von Knorring, L, Weinberger, D & Yamawaki, S 2012, 'World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance', The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, vol. 13, no. 5. https://doi.org/10.3109/15622975.2012.696143

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance. / Hasan, Alkomiet; Falkai, Peter; Wobrock, Thomas et al.
In: The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, Vol. 13, No. 5, 07.2012.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1

T2 - update 2012 on the acute treatment of schizophrenia and the management of treatment resistance

AU - Hasan, Alkomiet

AU - Falkai, Peter

AU - Wobrock, Thomas

AU - Glenthoj, Birte

AU - Gattaz, Wagner F

AU - Thibaut, Florence

A2 - Altamura, A Carlo

A2 - Andreasen, Nancy

A2 - Barnes, Thomas R E

A2 - Ceylan, M Emin

A2 - Ciprian Ollivier, Jorge

A2 - Crow, Timothy

A2 - Danaci, Aysen Esen

A2 - David, Anthony

A2 - Davidson, Michael

A2 - Deakin, Bill

A2 - Elkis, Helio

A2 - Farde, Lars

A2 - Gaebel, Wolfgang

A2 - Gallhofer, Bernd

A2 - Gerlach, Jes

A2 - Hirsch, Steven Richard

A2 - Hojaij, Carlos Roberto

A2 - Hwang, Michael

A2 - Hwo, Hai Gwo

A2 - Jablensky, Assen Verniaminov

A2 - Jarema, Marek

A2 - Kane, John

A2 - Kojima, Takuja

A2 - Larach, Veronica

A2 - Lieberman, Jeffrey

A2 - McGorry, Patrick

A2 - Meltzer, Herbert

A2 - Möller, Hans-Jürgen

A2 - Mosolov, S

A2 - Moussaoui, Driss

A2 - Olié, Jean-Pierre

A2 - Palha, Antonio Pacheco

A2 - Sarandöl, Asli

A2 - Sato, Mitsumoto

A2 - Sauer, Heinrich

A2 - Schooler, Nina

A2 - Taneli, Bilgen

A2 - von Knorring, Lars

A2 - Weinberger, Daniel

A2 - Yamawaki, Shigeto

PY - 2012/7

Y1 - 2012/7

N2 - These updated guidelines are based on a first edition of the World Federation of Societies of Biological Psychiatry Guidelines for Biological Treatment of Schizophrenia published in 2005. For this 2012 revision, all available publications pertaining to the biological treatment of schizophrenia were reviewed systematically to allow for an evidence-based update. These guidelines provide evidence-based practice recommendations that are clinically and scientifically meaningful and these guidelines are intended to be used by all physicians diagnosing and treating people suffering from schizophrenia. Based on the first version of these guidelines, a systematic review of the MEDLINE/PUBMED database and the Cochrane Library, in addition to data extraction from national treatment guidelines, has been performed for this update. The identified literature was evaluated with respect to the strength of evidence for its efficacy and then categorised into six levels of evidence (A-F; Bandelow et al. 2008b, World J Biol Psychiatry 9:242). This first part of the updated guidelines covers the general descriptions of antipsychotics and their side effects, the biological treatment of acute schizophrenia and the management of treatment-resistant schizophrenia.

AB - These updated guidelines are based on a first edition of the World Federation of Societies of Biological Psychiatry Guidelines for Biological Treatment of Schizophrenia published in 2005. For this 2012 revision, all available publications pertaining to the biological treatment of schizophrenia were reviewed systematically to allow for an evidence-based update. These guidelines provide evidence-based practice recommendations that are clinically and scientifically meaningful and these guidelines are intended to be used by all physicians diagnosing and treating people suffering from schizophrenia. Based on the first version of these guidelines, a systematic review of the MEDLINE/PUBMED database and the Cochrane Library, in addition to data extraction from national treatment guidelines, has been performed for this update. The identified literature was evaluated with respect to the strength of evidence for its efficacy and then categorised into six levels of evidence (A-F; Bandelow et al. 2008b, World J Biol Psychiatry 9:242). This first part of the updated guidelines covers the general descriptions of antipsychotics and their side effects, the biological treatment of acute schizophrenia and the management of treatment-resistant schizophrenia.

U2 - 10.3109/15622975.2012.696143

DO - 10.3109/15622975.2012.696143

M3 - Article

C2 - 22834451

SN - 1814-1412

VL - 13

JO - The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry

JF - The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry

IS - 5

ER -

Hasan A, Falkai P, Wobrock T, Glenthoj B, Gattaz WF, Thibaut F et al. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry. 2012 Jul;13(5). doi: 10.3109/15622975.2012.696143